Show Summary Details
Page of

Attitudes 

Attitudes
Chapter:
Attitudes
Author(s):

Dieter Schmidt

and Simon Shorvon

DOI:
10.1093/med/9780198725909.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 October 2020

It could be argued that the greatest advance in the field of epilepsy in the modern era has nothing to do with medicine, is not electroencephalography or magnetic resonance imaging or molecular biology, or the development of new drugs, but is in fact the change in societal attitudes towards those with epilepsy. Epilepsy is not only, or even most importantly, just a medical condition, but it is also something that happens to people, and it can destroy lives and livelihoods. There has been a welcome sea change in our opinions in recent years in the way people with epilepsy are treated and are regarded. All is not perfect by any means, and stigma is still present, but it surely is much less than it was in the early periods of the modern history of epilepsy, at least in Western cultures. This chapter charts the course of changing societal attitudes since 1860, through the dire years of theories of degeneration, eugenics, positivist criminology, and racial hygiene. There has been a transformation of epilepsy from the moral to the medical domain, from ‘badness’ to ‘sickness’, and this has certainly contributed to decreasing stigmatisation and deprecation. Much needs still to be done, and prejudice can flare up quickly; but nevertheless the public attitudes to epilepsy are far better now than in even the recent past.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.